[{"address1": "200-3650 Gilmore Way", "city": "Burnaby", "state": "BC", "zip": "V5G 4W8", "country": "Canada", "phone": "604 484 3300", "fax": "604 484 3450", "website": "https://www.xenon-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.", "fullTimeEmployees": 316, "companyOfficers": [{"maxAge": 1, "name": "Ms. Andrea  DiFabio J.D.", "age": 56, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 682252, "exercisedValue": 0, "unexercisedValue": 436894}, {"maxAge": 1, "name": "Dr. Christopher John Kenney M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 774702, "exercisedValue": 0, "unexercisedValue": 4053263}, {"maxAge": 1, "name": "Mr. Thomas Patrick Kelly J.D.", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew D. Ronsheim Ph.D.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley  McClCoskey B.A.", "age": 64, "title": "Executive Vice President of Human Resources", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robin P. Sherrington Ph.D.", "age": 63, "title": "Executive Vice President of Strategy & Innovation", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 587028, "exercisedValue": 0, "unexercisedValue": 9907717}, {"maxAge": 1, "name": "Dr. James R. Empfield Ph.D.", "age": 63, "title": "Executive Vice President of Drug Discovery", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 323428, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darren S. Cline M.B.A.", "age": 60, "title": "Chief Commercial Officer and Member of Executive Team", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "J.P.  Gilbert", "title": "Senior Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 2, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 5, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 41.2, "open": 41.53, "dayLow": 40.72, "dayHigh": 41.69, "regularMarketPreviousClose": 41.2, "regularMarketOpen": 41.53, "regularMarketDayLow": 40.72, "regularMarketDayHigh": 41.69, "payoutRatio": 0.0, "beta": 1.142, "forwardPE": -11.449438, "volume": 843941, "regularMarketVolume": 829949, "averageVolume": 833089, "averageVolume10days": 750580, "averageDailyVolume10Day": 750580, "bid": 40.63, "ask": 41.03, "bidSize": 8, "askSize": 8, "marketCap": 3142832384, "fiftyTwoWeekLow": 26.74, "fiftyTwoWeekHigh": 46.0, "allTimeHigh": 50.99, "allTimeLow": 2.1, "priceToSalesTrailing12Months": 419.0443, "fiftyDayAverage": 38.8994, "twoHundredDayAverage": 35.631275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2664002304, "profitMargins": 0.0, "floatShares": 71595819, "sharesOutstanding": 77105799, "sharesShort": 6148669, "sharesShortPriorMonth": 7040555, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0797, "heldPercentInsiders": 0.0014300001, "heldPercentInstitutions": 1.10648, "shortRatio": 7.91, "shortPercentOfFloat": 0.0889, "impliedSharesOutstanding": 77938148, "bookValue": 8.24, "priceToBook": 4.946602, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -278228000, "trailingEps": -3.55, "forwardEps": -3.56, "enterpriseToRevenue": 355.2, "enterpriseToEbitda": -8.444, "52WeekChange": -0.023478687, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 40.76, "targetHighPrice": 65.0, "targetLowPrice": 43.0, "targetMeanPrice": 55.03, "targetMedianPrice": 55.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 19, "totalCash": 487544992, "totalCashPerShare": 6.323, "ebitda": -315496000, "totalDebt": 8715000, "quickRatio": 14.786, "currentRatio": 15.138, "totalRevenue": 7500000, "debtToEquity": 1.375, "revenuePerShare": 0.096, "returnOnAssets": -0.25518, "returnOnEquity": -0.37649, "grossProfits": -245127008, "freeCashflow": -149782000, "operatingCashflow": -229935008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -42.416, "financialCurrency": "USD", "symbol": "XENE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1761340395, "regularMarketTime": 1761336000, "exchange": "NGM", "messageBoardId": "finmb_565718", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.06797, "regularMarketPrice": 40.76, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1415197800000, "postMarketChangePercent": -1.32482, "postMarketPrice": 40.22, "postMarketChange": -0.539997, "regularMarketChange": -0.440002, "regularMarketDayRange": "40.72 - 41.69", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 833089, "fiftyTwoWeekLowChange": 14.019999, "fiftyTwoWeekLowChangePercent": 0.5243081, "fiftyTwoWeekRange": "26.74 - 46.0", "fiftyTwoWeekHighChange": -5.2400017, "fiftyTwoWeekHighChangePercent": -0.11391308, "fiftyTwoWeekChangePercent": -2.3478687, "earningsTimestamp": 1754942400, "earningsTimestampStart": 1762804800, "earningsTimestampEnd": 1762804800, "earningsCallTimestampStart": 1754944200, "earningsCallTimestampEnd": 1754944200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.55, "epsForward": -3.56, "epsCurrentYear": -4.28858, "priceEpsCurrentYear": -9.504312, "fiftyDayAverageChange": 1.8605995, "fiftyDayAverageChangePercent": 0.047831062, "twoHundredDayAverageChange": 5.128723, "twoHundredDayAverageChangePercent": 0.14393881, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "shortName": "Xenon Pharmaceuticals Inc.", "longName": "Xenon Pharmaceuticals Inc.", "marketState": "CLOSED", "displayName": "Xenon Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]